Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MRMEs in Advanced Solid Tumors
NCT07563972Phase 1Recruiting
- Sponsor
- West China Hospital of Sichuan University
- Start
- May 2026
- Primary completion
- Mar 2027
- Countries
- 1
01
Overview
Phase 1, open-label trial in solid tumor (advanced stage) (3 arms), sponsored by West China Hospital of Sichuan University. Primary endpoint: Incidence of Dose-Limiting Toxicity at 4 weeks. Started May 2026; status: recruiting.
02
Conditions
solid tumor (advanced stage)
Beyond the preview
Go deeper on NCT07563972.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07563972.